GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Sito Bio-technology Co Ltd (SZSE:300583) » Definitions » Operating Margin %

Shandong Sito Bio-technology Co (SZSE:300583) Operating Margin % : 7.97% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shandong Sito Bio-technology Co Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Shandong Sito Bio-technology Co's Operating Income for the three months ended in Mar. 2024 was ¥19 Mil. Shandong Sito Bio-technology Co's Revenue for the three months ended in Mar. 2024 was ¥244 Mil. Therefore, Shandong Sito Bio-technology Co's Operating Margin % for the quarter that ended in Mar. 2024 was 7.97%.

The historical rank and industry rank for Shandong Sito Bio-technology Co's Operating Margin % or its related term are showing as below:

SZSE:300583' s Operating Margin % Range Over the Past 10 Years
Min: -8.71   Med: 10.38   Max: 39.03
Current: 6.07


SZSE:300583's Operating Margin % is ranked better than
80.53% of 1017 companies
in the Biotechnology industry
Industry Median: -155.93 vs SZSE:300583: 6.07

Shandong Sito Bio-technology Co's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Shandong Sito Bio-technology Co's Operating Income for the three months ended in Mar. 2024 was ¥19 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was ¥72 Mil.

Warning Sign:

Shandong Sito Bio-technology Co Ltd has recorded a loss in operating income at least once over the past 3 years.


Shandong Sito Bio-technology Co Operating Margin % Historical Data

The historical data trend for Shandong Sito Bio-technology Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Sito Bio-technology Co Operating Margin % Chart

Shandong Sito Bio-technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.96 -8.71 8.07 6.38 6.62

Shandong Sito Bio-technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.59 11.53 1.55 3.01 7.97

Competitive Comparison of Shandong Sito Bio-technology Co's Operating Margin %

For the Biotechnology subindustry, Shandong Sito Bio-technology Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Sito Bio-technology Co's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Sito Bio-technology Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Shandong Sito Bio-technology Co's Operating Margin % falls into.



Shandong Sito Bio-technology Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Shandong Sito Bio-technology Co's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=84.769 / 1279.783
=6.62 %

Shandong Sito Bio-technology Co's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=19.47 / 244.396
=7.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Sito Bio-technology Co  (SZSE:300583) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Shandong Sito Bio-technology Co Operating Margin % Related Terms

Thank you for viewing the detailed overview of Shandong Sito Bio-technology Co's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Sito Bio-technology Co (SZSE:300583) Business Description

Traded in Other Exchanges
N/A
Address
South Section of East Outer Ring Road, Dingtao County, Shandong Province, Heze, CHN, 274000
Shandong Sito Bio-technology Co Ltd is a biotechnology company. It is specialized in the research and development and production of core derivatives and derivatives of new steroid hormone drugs. The company offers bio-steroidal drug raw materials such as androstenedione, nonhydroxyandrostenedione and androstenedione.
Executives
Mi Qi Directors, executives
Wang Min Director
Kong Qing Zhi Executives
He Jian Yong Directors, executives
Ceng Qing Li Securities Affairs Representative

Shandong Sito Bio-technology Co (SZSE:300583) Headlines

No Headlines